What we need is to work across Europe to build world-class, publicly controlled medical research capacity. Then, rather than handing over that research \u2014 or, indeed, the patient data underlying it \u2014 to the pharma cartel, we need to develop a different model of intellectual property protection that allows for the sharing and licensing of research in a way that supports international collaboration to produce better medicines for all.<\/p>\n
Such an approach wouldn\u2019t just undercut Trump\u2019s plans to enhance U.S. power, it would also mean no longer treating lifesaving medical knowledge as commercial property that only the richest can afford.<\/p>\n
Knowledge is the lifeblood of modern society, we are told \u2014 so, why are we allowing private interests to wall it off for decades?<\/p>\n
In the meantime, we need to build manufacturing capacity as well. The public sector doesn\u2019t have to produce every medicine our society needs, but in an increasingly insecure world, we do need more homegrown capacity. That means a more balanced range of private sector companies involved in medicines, as well as better public sector capacity, so we can\u2019t be held to ransom.<\/p>\n
Finally, given the long-term impact that cuts to U.S. and European aid will have on health care globally, we should work with countries in the global south to help boost their production capacity too. As things stand, too many nations have been discouraged from addressing their local health needs. And we should be supporting them with our know-how, technology transfer and a different intellectual property model.<\/p>\n
We can have a world where everyone has access to the medicines they need. But both Trump and Big Pharma will push us in the opposite direction. It\u2019s time for something else.<\/p>\n","protected":false},"excerpt":{"rendered":"What we need is to work across Europe to build world-class, publicly controlled medical research capacity. Then, rather…\n","protected":false},"author":2,"featured_media":102360,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5174],"tags":[32,12849,2000,6562,299,5187,3941,6854,5769,47303,10057,32755,2443,10689,6648,479,1201,15,49],"class_list":{"0":"post-102359","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eu","8":"tag-donald-trump","9":"tag-drug-pricing","10":"tag-eu","11":"tag-eu27","12":"tag-europe","13":"tag-european","14":"tag-health-care","15":"tag-intellectual-property","16":"tag-medicines","17":"tag-medicines-manufacturing","18":"tag-pharma","19":"tag-public-private-partnerships","20":"tag-regulation","21":"tag-research-and-development","22":"tag-supply-chains","23":"tag-tariffs","24":"tag-trade","25":"tag-united-kingdom","26":"tag-united-states"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114509474068055490","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/102359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=102359"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/102359\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/102360"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=102359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=102359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=102359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}